Published : 30 Oct 2012
The Australian drug delivery technology company has succeeded in making another licensing deal with an Indian major with operations and sells across the world. The deal is an exclusive global license agreement of the TPM® technology to the licensee company for its use in an antibiotic injectable product.
The licensee has one of the largest sterile capacity in India and amongst the largest lyophilization (freeze drying) capacities in the world with its operations spread over nine world-class manufacturing facilities around the globe. The company is focused on developing and commercializing new products for key therapeutic markets targeting anti-infective, oncology, central nervous system (CNS), gastro-intestinal (GI), ophthalmic and peptides.
This is the third Indian large Pharma major to conclude licensing deal with Australian client of Aagami.